Attached files

file filename
10-K/A - 10-K/A - JUNIPER PHARMACEUTICALS INCjnp-10ka_20171231.htm
EX-31.2 - EX-31.2 - JUNIPER PHARMACEUTICALS INCjnp-ex312_6.htm

 

Exhibit 31.1

Certification Pursuant to Rule 13a-14(a)/15d-14(a)

of the Securities Exchange Act of 1934

I, Alicia Secor, certify that:

1. I have reviewed this Amendment to the Annual Report on Form 10-K/A of Juniper Pharmaceuticals, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

/s/ Alicia Secor 

Alicia Secor

President and Chief Executive Officer

(Principal Executive Officer)

DATE: April 27, 2018